Skip to main content
Top
Published in: Clinical Reviews in Allergy & Immunology 3/2017

01-12-2017

Cutaneous Manifestations of ANCA-Associated Small Vessels Vasculitis

Authors: Angelo Valerio Marzano, Maria Gabriella Raimondo, Emilio Berti, Pier Luigi Meroni, Francesca Ingegnoli

Published in: Clinical Reviews in Allergy & Immunology | Issue 3/2017

Login to get access

Abstract

Skin lesions are frequent manifestations of underlying systemic conditions, including systemic autoimmune vasculitis. In particular, anti-neutrophil cytoplasmic antibodies (ANCA) are associated with distinct forms of vasculitis characterized by inflammatory cell infiltration of the walls of small and medium-sized vessels leading to vascular destruction and tissue necrosis. ANCA-associated vasculitis is rare and systemic diseases, which can be classified based on different distribution of vascular inflammation and presence or absence of granulomatosis and asthma. Despite their diversities, ANCA-associated vasculitis, namely microscopic polyangiitis, granulomatosis with polyangiitis and eosinophilic granulomatosis with polyangiitis, can all display a broad variety of cutaneous manifestations, which can appear during the course of the disease or even as first sign at the time of onset. Different skin manifestations might coexist in the same patient and occur in different occasions during the course of the vasculitis. Thus, a deep knowledge of the spectrum of skin lesions as part of ANCA-associated vasculitis is mandatory for a correct diagnostic process, whenever cutaneous vasculitis is suspected. Due to this broad variety of manifestations, the diagnosis of skin involvement in ANCA-associated vasculitis is very challenging and it must be supported by a detailed medical history, accurate physical examination, specific histopathological analysis of skin biopsy and the presence of ANCA serology. In this review, we focus on the cutaneous manifestations that can develop in the context of ANCA-associated vasculitis, detailing the clinical features, the histopathological aspects as well as the direct immunofluorescence studies for each of the three conditions. Moreover, we acknowledged the differential diagnoses that must be ruled out in the diagnostic process and the main therapeutic approaches available for treatment of ANCA-associated vasculitis.
Literature
3.
go back to reference Damoiseaux J, Csernok E, Rasmussen N, Moosig F, van Paassen P, Baslund B, Vermeersch P, Blockmans D, Cohen Tervaert JW, Bossuyt X (2016) Detection of antineutrophil cytoplasmic antibodies (ANCAs): a multicentre European Vasculitis Study Group (EUVAS) evaluation of the value of indirect immunofluorescence (IIF) versus antigen-specific immunoassays. Ann Rheum dis 76(4):647–653. doi:10.1136/annrheumdis-2016-209507 CrossRefPubMed Damoiseaux J, Csernok E, Rasmussen N, Moosig F, van Paassen P, Baslund B, Vermeersch P, Blockmans D, Cohen Tervaert JW, Bossuyt X (2016) Detection of antineutrophil cytoplasmic antibodies (ANCAs): a multicentre European Vasculitis Study Group (EUVAS) evaluation of the value of indirect immunofluorescence (IIF) versus antigen-specific immunoassays. Ann Rheum dis 76(4):647–653. doi:10.​1136/​annrheumdis-2016-209507 CrossRefPubMed
5.
go back to reference Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, Flores-Suarez LF, Gross WL, Guillevin L, Hagen EC, Hoffman GS, Jayne DR, Kallenberg CG, Lamprecht P, Langford CA, Luqmani RA, Mahr AD, Matteson EL, Merkel PA, Ozen S, Pusey CD, Rasmussen N, Rees AJ, Scott DG, Specks U, Stone JH, Takahashi K, Watts RA (2013) 2012 revised International Chapel Hill Consensus Conference Nomenclature of vasculitides. Arthritis Rheum 65(1):1–11. doi:10.1002/art.37715 CrossRefPubMed Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, Flores-Suarez LF, Gross WL, Guillevin L, Hagen EC, Hoffman GS, Jayne DR, Kallenberg CG, Lamprecht P, Langford CA, Luqmani RA, Mahr AD, Matteson EL, Merkel PA, Ozen S, Pusey CD, Rasmussen N, Rees AJ, Scott DG, Specks U, Stone JH, Takahashi K, Watts RA (2013) 2012 revised International Chapel Hill Consensus Conference Nomenclature of vasculitides. Arthritis Rheum 65(1):1–11. doi:10.​1002/​art.​37715 CrossRefPubMed
6.
go back to reference Watts RA, Mahr A, Mohammad AJ, Gatenby P, Basu N, Flores-Suarez LF (2015) Classification, epidemiology and clinical subgrouping of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis. Nephrol Dial Transplant 30(Suppl 1):i14–i22. doi:10.1093/ndt/gfv022 CrossRefPubMed Watts RA, Mahr A, Mohammad AJ, Gatenby P, Basu N, Flores-Suarez LF (2015) Classification, epidemiology and clinical subgrouping of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis. Nephrol Dial Transplant 30(Suppl 1):i14–i22. doi:10.​1093/​ndt/​gfv022 CrossRefPubMed
7.
go back to reference Mohammad AJ, Jacobsson LT, Westman KW, Sturfelt G, Segelmark M (2009) Incidence and survival rates in Wegener’s granulomatosis, microscopic polyangiitis, Churg-Strauss syndrome and polyarteritis nodosa. Rheumatology (Oxford) 48(12):1560–1565. doi:10.1093/rheumatology/kep304 CrossRef Mohammad AJ, Jacobsson LT, Westman KW, Sturfelt G, Segelmark M (2009) Incidence and survival rates in Wegener’s granulomatosis, microscopic polyangiitis, Churg-Strauss syndrome and polyarteritis nodosa. Rheumatology (Oxford) 48(12):1560–1565. doi:10.​1093/​rheumatology/​kep304 CrossRef
9.
go back to reference Calatroni M, Oliva E, Gianfreda D, Gregorini G, Allinovi M, Ramirez GA, Bozzolo EP, Monti S, Bracaglia C, Marucci G, Bodria M, Sinico RA, Pieruzzi F, Moroni G, Pastore S, Emmi G, Esposito P, Catanoso M, Barbano G, Bonanni A, Vaglio A (2017) ANCA-associated vasculitis in childhood: recent advances. Ital J Pediatr 43(1):46. doi:10.1186/s13052-017-0364-x CrossRefPubMedPubMedCentral Calatroni M, Oliva E, Gianfreda D, Gregorini G, Allinovi M, Ramirez GA, Bozzolo EP, Monti S, Bracaglia C, Marucci G, Bodria M, Sinico RA, Pieruzzi F, Moroni G, Pastore S, Emmi G, Esposito P, Catanoso M, Barbano G, Bonanni A, Vaglio A (2017) ANCA-associated vasculitis in childhood: recent advances. Ital J Pediatr 43(1):46. doi:10.​1186/​s13052-017-0364-x CrossRefPubMedPubMedCentral
10.
go back to reference Hoffman GS, Kerr GS, Leavitt RY, Hallahan CW, Lebovics RS, Travis WD, Rottem M, Fauci AS (1992) Wegener granulomatosis: an analysis of 158 patients. Ann Intern med 116(6):488–498CrossRefPubMed Hoffman GS, Kerr GS, Leavitt RY, Hallahan CW, Lebovics RS, Travis WD, Rottem M, Fauci AS (1992) Wegener granulomatosis: an analysis of 158 patients. Ann Intern med 116(6):488–498CrossRefPubMed
12.
go back to reference Chang DY, Wu LH, Liu G, Chen M, Kallenberg CG, Zhao MH (2012) Re-evaluation of the histopathologic classification of ANCA-associated glomerulonephritis: a study of 121 patients in a single center. Nephrol Dial Transplant 27(6):2343–2349. doi:10.1093/ndt/gfr643 CrossRefPubMed Chang DY, Wu LH, Liu G, Chen M, Kallenberg CG, Zhao MH (2012) Re-evaluation of the histopathologic classification of ANCA-associated glomerulonephritis: a study of 121 patients in a single center. Nephrol Dial Transplant 27(6):2343–2349. doi:10.​1093/​ndt/​gfr643 CrossRefPubMed
13.
go back to reference Mukhtyar C, Flossmann O, Hellmich B, Bacon P, Cid M, Cohen-Tervaert JW, Gross WL, Guillevin L, Jayne D, Mahr A, Merkel PA, Raspe H, Scott D, Witter J, Yazici H, Luqmani RA, European Vasculitis Study G (2008) Outcomes from studies of antineutrophil cytoplasm antibody associated vasculitis: a systematic review by the European league against rheumatism systemic vasculitis task force. Ann Rheum dis 67(7):1004–1010. doi:10.1136/ard.2007.071936 CrossRefPubMed Mukhtyar C, Flossmann O, Hellmich B, Bacon P, Cid M, Cohen-Tervaert JW, Gross WL, Guillevin L, Jayne D, Mahr A, Merkel PA, Raspe H, Scott D, Witter J, Yazici H, Luqmani RA, European Vasculitis Study G (2008) Outcomes from studies of antineutrophil cytoplasm antibody associated vasculitis: a systematic review by the European league against rheumatism systemic vasculitis task force. Ann Rheum dis 67(7):1004–1010. doi:10.​1136/​ard.​2007.​071936 CrossRefPubMed
14.
go back to reference Stone JH, Wegener’s Granulomatosis Etanercept Trial Research G (2003) Limited versus severe Wegener’s granulomatosis: baseline data on patients in the Wegener’s granulomatosis etanercept trial. Arthritis Rheum 48(8):2299–2309. doi:10.1002/art.11075 CrossRefPubMed Stone JH, Wegener’s Granulomatosis Etanercept Trial Research G (2003) Limited versus severe Wegener’s granulomatosis: baseline data on patients in the Wegener’s granulomatosis etanercept trial. Arthritis Rheum 48(8):2299–2309. doi:10.​1002/​art.​11075 CrossRefPubMed
15.
go back to reference Luqmani R, Suppiah R, Edwards CJ, Phillip R, Maskell J, Culliford D, Jayne D, Morishita K, Arden N (2011) Mortality in Wegener’s granulomatosis: a bimodal pattern. Rheumatology (Oxford) 50(4):697–702. doi:10.1093/rheumatology/keq351 CrossRef Luqmani R, Suppiah R, Edwards CJ, Phillip R, Maskell J, Culliford D, Jayne D, Morishita K, Arden N (2011) Mortality in Wegener’s granulomatosis: a bimodal pattern. Rheumatology (Oxford) 50(4):697–702. doi:10.​1093/​rheumatology/​keq351 CrossRef
17.
go back to reference Patten SF, Tomecki KJ (1993) Wegener’s granulomatosis: cutaneous and oral mucosal disease. J am Acad Dermatol 28(5 Pt 1):710–718CrossRefPubMed Patten SF, Tomecki KJ (1993) Wegener’s granulomatosis: cutaneous and oral mucosal disease. J am Acad Dermatol 28(5 Pt 1):710–718CrossRefPubMed
20.
go back to reference Holle JU, Gross WL, Holl-Ulrich K, Ambrosch P, Noelle B, Both M, Csernok E, Moosig F, Schinke S, Reinhold-Keller E (2010) Prospective long-term follow-up of patients with localised Wegener’s granulomatosis: does it occur as persistent disease stage? Ann Rheum Dis 69(11):1934–1939. doi:10.1136/ard.2010.130203 CrossRefPubMed Holle JU, Gross WL, Holl-Ulrich K, Ambrosch P, Noelle B, Both M, Csernok E, Moosig F, Schinke S, Reinhold-Keller E (2010) Prospective long-term follow-up of patients with localised Wegener’s granulomatosis: does it occur as persistent disease stage? Ann Rheum Dis 69(11):1934–1939. doi:10.​1136/​ard.​2010.​130203 CrossRefPubMed
23.
go back to reference Stewart C, Cohen D, Bhattacharyya I, Scheitler L, Riley S, Calamia K, Migliorati C, Baughman R, Langford P, Katz J (2007) Oral manifestations of Wegener’s granulomatosis: a report of three cases and a literature review. J Am Dent Assoc 138(3):338–348 quiz 396, 398CrossRefPubMed Stewart C, Cohen D, Bhattacharyya I, Scheitler L, Riley S, Calamia K, Migliorati C, Baughman R, Langford P, Katz J (2007) Oral manifestations of Wegener’s granulomatosis: a report of three cases and a literature review. J Am Dent Assoc 138(3):338–348 quiz 396, 398CrossRefPubMed
24.
go back to reference Marzano AV, Balice Y, Tavecchio S, Desimine C, Colombo A, Berti E (2015) Granulomatous vasculitis. G Ital Dermatol Venereol 150(2):193–202PubMed Marzano AV, Balice Y, Tavecchio S, Desimine C, Colombo A, Berti E (2015) Granulomatous vasculitis. G Ital Dermatol Venereol 150(2):193–202PubMed
25.
go back to reference Ozen S, Pistorio A, Iusan SM, Bakkaloglu A, Herlin T, Brik R, Buoncompagni A, Lazar C, Bilge I, Uziel Y, Rigante D, Cantarini L, Hilario MO, Silva CA, Alegria M, Norambuena X, Belot A, Berkun Y, Estrella AI, Olivieri AN, Alpigiani MG, Rumba I, Sztajnbok F, Tambic-Bukovac L, Breda L, Al-Mayouf S, Mihaylova D, Chasnyk V, Sengler C, Klein-Gitelman M, Djeddi D, Nuno L, Pruunsild C, Brunner J, Kondi A, Pagava K, Pederzoli S, Martini A, Ruperto N, Paediatric Rheumatology International Trials O (2010) EULAR/PRINTO/PRES criteria for Henoch-Schonlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: final classification criteria. Ann Rheum dis 69(5):798–806. doi:10.1136/ard.2009.116657 CrossRefPubMed Ozen S, Pistorio A, Iusan SM, Bakkaloglu A, Herlin T, Brik R, Buoncompagni A, Lazar C, Bilge I, Uziel Y, Rigante D, Cantarini L, Hilario MO, Silva CA, Alegria M, Norambuena X, Belot A, Berkun Y, Estrella AI, Olivieri AN, Alpigiani MG, Rumba I, Sztajnbok F, Tambic-Bukovac L, Breda L, Al-Mayouf S, Mihaylova D, Chasnyk V, Sengler C, Klein-Gitelman M, Djeddi D, Nuno L, Pruunsild C, Brunner J, Kondi A, Pagava K, Pederzoli S, Martini A, Ruperto N, Paediatric Rheumatology International Trials O (2010) EULAR/PRINTO/PRES criteria for Henoch-Schonlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: final classification criteria. Ann Rheum dis 69(5):798–806. doi:10.​1136/​ard.​2009.​116657 CrossRefPubMed
26.
go back to reference Gajic-Veljic M, Nikolic M, Peco-Antic A, Bogdanovic R, Andrejevic S, Bonaci-Nikolic B (2013) Granulomatosis with polyangiitis (Wegener’s granulomatosis) in children: report of three cases with cutaneous manifestations and literature review. Pediatr Dermatol 30(4):e37–e42. doi:10.1111/pde.12034 CrossRefPubMed Gajic-Veljic M, Nikolic M, Peco-Antic A, Bogdanovic R, Andrejevic S, Bonaci-Nikolic B (2013) Granulomatosis with polyangiitis (Wegener’s granulomatosis) in children: report of three cases with cutaneous manifestations and literature review. Pediatr Dermatol 30(4):e37–e42. doi:10.​1111/​pde.​12034 CrossRefPubMed
27.
go back to reference Decleva I, Marzano AV, Barbareschi M, Berti E (1997) Cutaneous manifestations in systemic vasculitis. Clin rev Allergy Immunol 15(1):5–20CrossRefPubMed Decleva I, Marzano AV, Barbareschi M, Berti E (1997) Cutaneous manifestations in systemic vasculitis. Clin rev Allergy Immunol 15(1):5–20CrossRefPubMed
30.
go back to reference Sinico RA, Di Toma L, Maggiore U, Tosoni C, Bottero P, Sabadini E, Giammarresi G, Tumiati B, Gregorini G, Pesci A, Monti S, Balestrieri G, Garini G, Vecchio F, Buzio C (2006) Renal involvement in Churg-Strauss syndrome. Am J Kidney Dis 47(5):770–779. doi:10.1053/j.ajkd.2006.01.026 CrossRefPubMed Sinico RA, Di Toma L, Maggiore U, Tosoni C, Bottero P, Sabadini E, Giammarresi G, Tumiati B, Gregorini G, Pesci A, Monti S, Balestrieri G, Garini G, Vecchio F, Buzio C (2006) Renal involvement in Churg-Strauss syndrome. Am J Kidney Dis 47(5):770–779. doi:10.​1053/​j.​ajkd.​2006.​01.​026 CrossRefPubMed
31.
go back to reference Comarmond C, Pagnoux C, Khellaf M, Cordier JF, Hamidou M, Viallard JF, Maurier F, Jouneau S, Bienvenu B, Puechal X, Aumaitre O, Le Guenno G, Le Quellec A, Cevallos R, Fain O, Godeau B, Seror R, Dunogue B, Mahr A, Guilpain P, Cohen P, Aouba A, Mouthon L, Guillevin L, French Vasculitis Study G (2013) Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): clinical characteristics and long-term follow-up of the 383 patients enrolled in the French Vasculitis Study Group cohort. Arthritis Rheum 65(1):270–281. doi:10.1002/art.37721 CrossRefPubMed Comarmond C, Pagnoux C, Khellaf M, Cordier JF, Hamidou M, Viallard JF, Maurier F, Jouneau S, Bienvenu B, Puechal X, Aumaitre O, Le Guenno G, Le Quellec A, Cevallos R, Fain O, Godeau B, Seror R, Dunogue B, Mahr A, Guilpain P, Cohen P, Aouba A, Mouthon L, Guillevin L, French Vasculitis Study G (2013) Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): clinical characteristics and long-term follow-up of the 383 patients enrolled in the French Vasculitis Study Group cohort. Arthritis Rheum 65(1):270–281. doi:10.​1002/​art.​37721 CrossRefPubMed
32.
go back to reference Sable-Fourtassou R, Cohen P, Mahr A, Pagnoux C, Mouthon L, Jayne D, Blockmans D, Cordier JF, Delaval P, Puechal X, Lauque D, Viallard JF, Zoulim A, Guillevin L, French Vasculitis Study G (2005) Antineutrophil cytoplasmic antibodies and the Churg-Strauss syndrome. Ann Intern Med 143(9):632–638CrossRefPubMed Sable-Fourtassou R, Cohen P, Mahr A, Pagnoux C, Mouthon L, Jayne D, Blockmans D, Cordier JF, Delaval P, Puechal X, Lauque D, Viallard JF, Zoulim A, Guillevin L, French Vasculitis Study G (2005) Antineutrophil cytoplasmic antibodies and the Churg-Strauss syndrome. Ann Intern Med 143(9):632–638CrossRefPubMed
34.
35.
go back to reference Mohammad AJ, Jacobsson LT, Mahr AD, Sturfelt G, Segelmark M (2007) Prevalence of Wegener’s granulomatosis, microscopic polyangiitis, polyarteritis nodosa and Churg-Strauss syndrome within a defined population in southern Sweden. Rheumatology (Oxford) 46(8):1329–1337. doi:10.1093/rheumatology/kem107 CrossRef Mohammad AJ, Jacobsson LT, Mahr AD, Sturfelt G, Segelmark M (2007) Prevalence of Wegener’s granulomatosis, microscopic polyangiitis, polyarteritis nodosa and Churg-Strauss syndrome within a defined population in southern Sweden. Rheumatology (Oxford) 46(8):1329–1337. doi:10.​1093/​rheumatology/​kem107 CrossRef
37.
go back to reference Niles JL, Bottinger EP, Saurina GR, Kelly KJ, Pan G, Collins AB, McCluskey RT (1996) The syndrome of lung hemorrhage and nephritis is usually an ANCA-associated condition. Arch Intern Med 156(4):440–445CrossRefPubMed Niles JL, Bottinger EP, Saurina GR, Kelly KJ, Pan G, Collins AB, McCluskey RT (1996) The syndrome of lung hemorrhage and nephritis is usually an ANCA-associated condition. Arch Intern Med 156(4):440–445CrossRefPubMed
38.
go back to reference Savage CO, Winearls CG, Evans DJ, Rees AJ, Lockwood CM (1985) Microscopic polyarteritis: presentation, pathology and prognosis. Q J Med 56(220):467–483PubMed Savage CO, Winearls CG, Evans DJ, Rees AJ, Lockwood CM (1985) Microscopic polyarteritis: presentation, pathology and prognosis. Q J Med 56(220):467–483PubMed
41.
go back to reference Kawakami T, Soma Y, Saito C, Ogawa H, Nagahuchi Y, Okazaki T, Ozaki S, Mizoguchi M (2006) Cutaneous manifestations in patients with microscopic polyangiitis: two case reports and a minireview. Acta Derm Venereol 86(2):144–147. doi:10.2340/00015555-0034 PubMed Kawakami T, Soma Y, Saito C, Ogawa H, Nagahuchi Y, Okazaki T, Ozaki S, Mizoguchi M (2006) Cutaneous manifestations in patients with microscopic polyangiitis: two case reports and a minireview. Acta Derm Venereol 86(2):144–147. doi:10.​2340/​00015555-0034 PubMed
44.
go back to reference Marzano AV, Menicanti C, Crosti C, Trevisan V (2013) Neutrophilic dermatoses and inflammatory bowel diseases. G Ital Dermatol Venereol 148(2):185–196PubMed Marzano AV, Menicanti C, Crosti C, Trevisan V (2013) Neutrophilic dermatoses and inflammatory bowel diseases. G Ital Dermatol Venereol 148(2):185–196PubMed
45.
go back to reference Seishima M, Oyama Z, Oda M (2004) Skin eruptions associated with microscopic polyangiitis. Eur J Dermatol 14(4):255–258PubMed Seishima M, Oyama Z, Oda M (2004) Skin eruptions associated with microscopic polyangiitis. Eur J Dermatol 14(4):255–258PubMed
51.
go back to reference Marzano AV, Ishak RS, Saibeni S, Crosti C, Meroni PL, Cugno M (2013) Autoinflammatory skin disorders in inflammatory bowel diseases, pyoderma gangrenosum and Sweet’s syndrome: a comprehensive review and disease classification criteria. Clin Rev Allergy Immunol 45(2):202–210. doi:10.1007/s12016-012-8351-x CrossRefPubMed Marzano AV, Ishak RS, Saibeni S, Crosti C, Meroni PL, Cugno M (2013) Autoinflammatory skin disorders in inflammatory bowel diseases, pyoderma gangrenosum and Sweet’s syndrome: a comprehensive review and disease classification criteria. Clin Rev Allergy Immunol 45(2):202–210. doi:10.​1007/​s12016-012-8351-x CrossRefPubMed
53.
go back to reference Marzano AV, Fanoni D, Antiga E, Quaglino P, Caproni M, Crosti C, Meroni PL, Cugno M (2014) Expression of cytokines, chemokines and other effector molecules in two prototypic autoinflammatory skin diseases, pyoderma gangrenosum and Sweet’s syndrome. Clin Exp Immunol 178(1):48–56. doi:10.1111/cei.12394 CrossRefPubMedPubMedCentral Marzano AV, Fanoni D, Antiga E, Quaglino P, Caproni M, Crosti C, Meroni PL, Cugno M (2014) Expression of cytokines, chemokines and other effector molecules in two prototypic autoinflammatory skin diseases, pyoderma gangrenosum and Sweet’s syndrome. Clin Exp Immunol 178(1):48–56. doi:10.​1111/​cei.​12394 CrossRefPubMedPubMedCentral
54.
go back to reference Gastman B, Hashem AM, Djohan R, Bernard S, Hendrickson M, Schwarz G, Gharb BB, Rampazzo A, Fernandez A, Zins J, Hoffman GS, Doumit G, Siemionow M, Papay F (2016) Malignant pyoderma associated with granulomatosis with polyangiitis (Wegener granulomatosis) as a unique indication for facial vascularized composite Allotransplantation: part I. Plast Reconstr Surg 137(6):1007e–1015e. doi:10.1097/PRS.0000000000002162 CrossRefPubMed Gastman B, Hashem AM, Djohan R, Bernard S, Hendrickson M, Schwarz G, Gharb BB, Rampazzo A, Fernandez A, Zins J, Hoffman GS, Doumit G, Siemionow M, Papay F (2016) Malignant pyoderma associated with granulomatosis with polyangiitis (Wegener granulomatosis) as a unique indication for facial vascularized composite Allotransplantation: part I. Plast Reconstr Surg 137(6):1007e–1015e. doi:10.​1097/​PRS.​0000000000002162​ CrossRefPubMed
55.
go back to reference Jeong HS, Layher H, Cao L, Vandergriff T, Dominguez AR (2016) Pyoderma gangrenosum (PG) associated with levamisole-adulterated cocaine: clinical, serologic, and histopathologic findings in a cohort of patients. J am Acad Dermatol 74(5):892–898. doi:10.1016/j.jaad.2015.11.040 CrossRefPubMed Jeong HS, Layher H, Cao L, Vandergriff T, Dominguez AR (2016) Pyoderma gangrenosum (PG) associated with levamisole-adulterated cocaine: clinical, serologic, and histopathologic findings in a cohort of patients. J am Acad Dermatol 74(5):892–898. doi:10.​1016/​j.​jaad.​2015.​11.​040 CrossRefPubMed
56.
go back to reference Jimenez-Gallo D, Albarran-Planelles C, Linares-Barrios M, Rodriguez-Hernandez C, Martinez-Rodriguez A, Garcia-Moreno E, Bravo-Monge R (2013) Pyoderma gangrenosum and Wegener granulomatosis-like syndrome induced by cocaine. Clin Exp Dermatol 38(8):878–882. doi:10.1111/ced.12207 CrossRefPubMed Jimenez-Gallo D, Albarran-Planelles C, Linares-Barrios M, Rodriguez-Hernandez C, Martinez-Rodriguez A, Garcia-Moreno E, Bravo-Monge R (2013) Pyoderma gangrenosum and Wegener granulomatosis-like syndrome induced by cocaine. Clin Exp Dermatol 38(8):878–882. doi:10.​1111/​ced.​12207 CrossRefPubMed
58.
go back to reference Yates M, Watts RA, Bajema IM, Cid MC, Crestani B, Hauser T, Hellmich B, Holle JU, Laudien M, Little MA, Luqmani RA, Mahr A, Merkel PA, Mills J, Mooney J, Segelmark M, Tesar V, Westman K, Vaglio A, Yalcindag N, Jayne DR, Mukhtyar C (2016) EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis. Ann Rheum dis 75(9):1583–1594. doi:10.1136/annrheumdis-2016-209133 CrossRefPubMed Yates M, Watts RA, Bajema IM, Cid MC, Crestani B, Hauser T, Hellmich B, Holle JU, Laudien M, Little MA, Luqmani RA, Mahr A, Merkel PA, Mills J, Mooney J, Segelmark M, Tesar V, Westman K, Vaglio A, Yalcindag N, Jayne DR, Mukhtyar C (2016) EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis. Ann Rheum dis 75(9):1583–1594. doi:10.​1136/​annrheumdis-2016-209133 CrossRefPubMed
59.
go back to reference Guillevin L, Cordier JF, Lhote F, Cohen P, Jarrousse B, Royer I, Lesavre P, Jacquot C, Bindi P, Bielefeld P, Desson JF, Detree F, Dubois A, Hachulla E, Hoen B, Jacomy D, Seigneuric C, Lauque D, Stern M, Longy-Boursier M (1997) A prospective, multicenter, randomized trial comparing steroids and pulse cyclophosphamide versus steroids and oral cyclophosphamide in the treatment of generalized Wegener’s granulomatosis. Arthritis Rheum 40(12):2187–2198. doi:10.1002/1529-0131 (199712)40:12<2187::AID-ART12>3.0.CO;2-HCrossRefPubMed Guillevin L, Cordier JF, Lhote F, Cohen P, Jarrousse B, Royer I, Lesavre P, Jacquot C, Bindi P, Bielefeld P, Desson JF, Detree F, Dubois A, Hachulla E, Hoen B, Jacomy D, Seigneuric C, Lauque D, Stern M, Longy-Boursier M (1997) A prospective, multicenter, randomized trial comparing steroids and pulse cyclophosphamide versus steroids and oral cyclophosphamide in the treatment of generalized Wegener’s granulomatosis. Arthritis Rheum 40(12):2187–2198. doi:10.​1002/​1529-0131 (199712)40:12<2187::AID-ART12>3.0.CO;2-HCrossRefPubMed
60.
go back to reference Jayne D, Rasmussen N, Andrassy K, Bacon P, Tervaert JW, Dadoniene J, Ekstrand A, Gaskin G, Gregorini G, de Groot K, Gross W, Hagen EC, Mirapeix E, Pettersson E, Siegert C, Sinico A, Tesar V, Westman K, Pusey C, European Vasculitis Study G (2003) A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies. N Engl J Med 349(1):36–44. doi:10.1056/NEJMoa020286 CrossRefPubMed Jayne D, Rasmussen N, Andrassy K, Bacon P, Tervaert JW, Dadoniene J, Ekstrand A, Gaskin G, Gregorini G, de Groot K, Gross W, Hagen EC, Mirapeix E, Pettersson E, Siegert C, Sinico A, Tesar V, Westman K, Pusey C, European Vasculitis Study G (2003) A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies. N Engl J Med 349(1):36–44. doi:10.​1056/​NEJMoa020286 CrossRefPubMed
61.
go back to reference Hogan SL, Falk RJ, Chin H, Cai J, Jennette CE, Jennette JC, Nachman PH (2005) Predictors of relapse and treatment resistance in antineutrophil cytoplasmic antibody-associated small-vessel vasculitis. Ann Intern Med 143(9):621–631CrossRefPubMed Hogan SL, Falk RJ, Chin H, Cai J, Jennette CE, Jennette JC, Nachman PH (2005) Predictors of relapse and treatment resistance in antineutrophil cytoplasmic antibody-associated small-vessel vasculitis. Ann Intern Med 143(9):621–631CrossRefPubMed
62.
go back to reference De Groot K, Rasmussen N, Bacon PA, Tervaert JW, Feighery C, Gregorini G, Gross WL, Luqmani R, Jayne DR (2005) Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum 52(8):2461–2469. doi:10.1002/art.21142 CrossRefPubMed De Groot K, Rasmussen N, Bacon PA, Tervaert JW, Feighery C, Gregorini G, Gross WL, Luqmani R, Jayne DR (2005) Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum 52(8):2461–2469. doi:10.​1002/​art.​21142 CrossRefPubMed
63.
64.
go back to reference Pagnoux C, Mahr A, Hamidou MA, Boffa JJ, Ruivard M, Ducroix JP, Kyndt X, Lifermann F, Papo T, Lambert M, Le Noach J, Khellaf M, Merrien D, Puechal X, Vinzio S, Cohen P, Mouthon L, Cordier JF, Guillevin L, French Vasculitis Study G (2008) Azathioprine or methotrexate maintenance for ANCA-associated vasculitis. N Engl J med 359(26):2790–2803. doi:10.1056/NEJMoa0802311 CrossRefPubMed Pagnoux C, Mahr A, Hamidou MA, Boffa JJ, Ruivard M, Ducroix JP, Kyndt X, Lifermann F, Papo T, Lambert M, Le Noach J, Khellaf M, Merrien D, Puechal X, Vinzio S, Cohen P, Mouthon L, Cordier JF, Guillevin L, French Vasculitis Study G (2008) Azathioprine or methotrexate maintenance for ANCA-associated vasculitis. N Engl J med 359(26):2790–2803. doi:10.​1056/​NEJMoa0802311 CrossRefPubMed
65.
go back to reference de Groot K, Harper L, Jayne DR, Flores Suarez LF, Gregorini G, Gross WL, Luqmani R, Pusey CD, Rasmussen N, Sinico RA, Tesar V, Vanhille P, Westman K, Savage CO, Euvas (2009) Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized trial. Ann Intern Med 150(10):670–680CrossRefPubMed de Groot K, Harper L, Jayne DR, Flores Suarez LF, Gregorini G, Gross WL, Luqmani R, Pusey CD, Rasmussen N, Sinico RA, Tesar V, Vanhille P, Westman K, Savage CO, Euvas (2009) Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized trial. Ann Intern Med 150(10):670–680CrossRefPubMed
67.
go back to reference Stone JH, Merkel PA, Spiera R, Seo P, Langford CA, Hoffman GS, Kallenberg CG, St Clair EW, Turkiewicz A, Tchao NK, Webber L, Ding L, Sejismundo LP, Mieras K, Weitzenkamp D, Ikle D, Seyfert-Margolis V, Mueller M, Brunetta P, Allen NB, Fervenza FC, Geetha D, Keogh KA, Kissin EY, Monach PA, Peikert T, Stegeman C, Ytterberg SR, Specks U, Group R-IR (2010) Rituximab versus cyclophosphamide for ANCA-associated vasculitis. N Engl J Med 363(3):221–232. doi:10.1056/NEJMoa0909905 CrossRefPubMedPubMedCentral Stone JH, Merkel PA, Spiera R, Seo P, Langford CA, Hoffman GS, Kallenberg CG, St Clair EW, Turkiewicz A, Tchao NK, Webber L, Ding L, Sejismundo LP, Mieras K, Weitzenkamp D, Ikle D, Seyfert-Margolis V, Mueller M, Brunetta P, Allen NB, Fervenza FC, Geetha D, Keogh KA, Kissin EY, Monach PA, Peikert T, Stegeman C, Ytterberg SR, Specks U, Group R-IR (2010) Rituximab versus cyclophosphamide for ANCA-associated vasculitis. N Engl J Med 363(3):221–232. doi:10.​1056/​NEJMoa0909905 CrossRefPubMedPubMedCentral
68.
go back to reference Specks U, Merkel PA, Seo P, Spiera R, Langford CA, Hoffman GS, Kallenberg CG, St Clair EW, Fessler BJ, Ding L, Viviano L, Tchao NK, Phippard DJ, Asare AL, Lim N, Ikle D, Jepson B, Brunetta P, Allen NB, Fervenza FC, Geetha D, Keogh K, Kissin EY, Monach PA, Peikert T, Stegeman C, Ytterberg SR, Mueller M, Sejismundo LP, Mieras K, Stone JH, Group R-IR (2013) Efficacy of remission-induction regimens for ANCA-associated vasculitis. N Engl J Med 369(5):417–427. doi:10.1056/NEJMoa1213277 CrossRefPubMed Specks U, Merkel PA, Seo P, Spiera R, Langford CA, Hoffman GS, Kallenberg CG, St Clair EW, Fessler BJ, Ding L, Viviano L, Tchao NK, Phippard DJ, Asare AL, Lim N, Ikle D, Jepson B, Brunetta P, Allen NB, Fervenza FC, Geetha D, Keogh K, Kissin EY, Monach PA, Peikert T, Stegeman C, Ytterberg SR, Mueller M, Sejismundo LP, Mieras K, Stone JH, Group R-IR (2013) Efficacy of remission-induction regimens for ANCA-associated vasculitis. N Engl J Med 369(5):417–427. doi:10.​1056/​NEJMoa1213277 CrossRefPubMed
Metadata
Title
Cutaneous Manifestations of ANCA-Associated Small Vessels Vasculitis
Authors
Angelo Valerio Marzano
Maria Gabriella Raimondo
Emilio Berti
Pier Luigi Meroni
Francesca Ingegnoli
Publication date
01-12-2017
Publisher
Springer US
Published in
Clinical Reviews in Allergy & Immunology / Issue 3/2017
Print ISSN: 1080-0549
Electronic ISSN: 1559-0267
DOI
https://doi.org/10.1007/s12016-017-8616-5

Other articles of this Issue 3/2017

Clinical Reviews in Allergy & Immunology 3/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.